121 related articles for article (PubMed ID: 34724107)
1. Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study.
Chen JX; Sun JW; Wang Y; Pan T; Zhuang LP; Lin LZ; Lv BC
Surg Today; 2022 May; 52(5):783-794. PubMed ID: 34724107
[TBL] [Abstract][Full Text] [Related]
2. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
[TBL] [Abstract][Full Text] [Related]
3. Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis.
Zhang Y; Cao Y; Zhang J; Huang M; Roy P; Huang B; Yang H; Rong Y; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Lin J; Zhang J; Fu J; He J; Li H
Ann Surg; 2023 Jun; 277(6):e1239-e1246. PubMed ID: 35797545
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.
Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P
World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363
[TBL] [Abstract][Full Text] [Related]
5. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H
Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113
[TBL] [Abstract][Full Text] [Related]
6. A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large-Sample Retrospective Study.
Que SJ; Zhong Q; Chen QY; Truty MJ; Yan S; Ma YB; Ding FH; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
World J Surg; 2023 Jul; 47(7):1762-1771. PubMed ID: 37069317
[TBL] [Abstract][Full Text] [Related]
7. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system.
Li Z; Wang Y; Shan F; Ying X; Wu Z; Xue K; Miao R; Zhang Y; Ji J
Gastric Cancer; 2018 Nov; 21(6):977-987. PubMed ID: 29748876
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
[TBL] [Abstract][Full Text] [Related]
9. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
[TBL] [Abstract][Full Text] [Related]
10. Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.
Zhao LY; Li CC; Jia LY; Chen XL; Zhang WH; Chen XZ; Yang K; Liu K; Wang YG; Xue L; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Aug; 7(32):51069-51081. PubMed ID: 27363014
[TBL] [Abstract][Full Text] [Related]
11. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
Lin JX; Yoon C; Desiderio J; Yi BC; Li P; Zheng CH; Parisi A; Huang CM; Strong VE; Yoon SS
Br J Surg; 2019 Aug; 106(9):1187-1196. PubMed ID: 31197829
[TBL] [Abstract][Full Text] [Related]
14. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.
Gu P; Deng J; Sun Z; Wang Z; Wang W; Liang H; Xu H; Zhou Z
Surg Today; 2021 Jan; 51(1):101-110. PubMed ID: 32754844
[TBL] [Abstract][Full Text] [Related]
15. Positive lymph node ratio is an index in predicting prognosis for remnant gastric cancer with insufficient retrieved lymph node in R0 resection.
Wang H; Qi H; Liu X; Gao Z; Hidasa I; Aikebaier A; Li K
Sci Rep; 2021 Jan; 11(1):2022. PubMed ID: 33479327
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of three lymph node staging systems in predicting overall survival for gastric cancer patients after radical resection].
Luo C; Zhang G; Wang W; Zhou Z; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1107-1112. PubMed ID: 27781245
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Four Lymph Node Staging Systems in Gastric Adenocarcinoma after Neoadjuvant Therapy - A Population-Based Study.
Lai H; Zheng J; Li Y
Front Surg; 2022; 9():918198. PubMed ID: 35756471
[TBL] [Abstract][Full Text] [Related]
20. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
